STATE STREET CORP - AVIRAGEN THERAPEUTICS INC ownership

AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 32 filers reported holding AVIRAGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AVIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$13,000
-23.5%
23,8200.0%0.00%
Q3 2017$17,000
+13.3%
23,8200.0%0.00%
Q2 2017$15,0000.0%23,8200.0%0.00%
Q1 2017$15,000
-50.0%
23,8200.0%0.00%
Q4 2016$30,000
-34.8%
23,8200.0%0.00%
Q3 2016$46,000
+39.4%
23,8200.0%0.00%
Q2 2016$33,000
-8.3%
23,8200.0%0.00%
Q1 2016$36,00023,8200.00%
Other shareholders
AVIRAGEN THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 2,809,531$1,591,0000.50%
Carlson Capital Management 156,485$89,0000.02%
GABELLI & Co INVESTMENT ADVISERS, INC. 224,477$127,0000.02%
TOWERVIEW LLC 35,000$20,0000.01%
WEDBUSH SECURITIES INC 24,735$14,0000.00%
Virtu Financial LLC 33,206$19,0000.00%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 127,366$72,0000.00%
BREWIN DOLPHIN LTD 7,728$4,3760.00%
Renaissance Technologies 1,344,905$762,0000.00%
Riggs Asset Managment Co. Inc. 666$00.00%
View complete list of AVIRAGEN THERAPEUTICS INC shareholders